3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Thyroid cancer, Hurthle cell
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Adenocarcinoma, Follicular
1
Interventions
Magnetic Resonance Spectroscopy
17
Iodine-131
16
lenvatinib
13
trametinib
12
Thyrotropin Alfa
11
Sorafenib
11
pembrolizumab
10
dabrafenib
10
Paclitaxel
9
vandetanib
8
Thyroxine
8
Surgical Procedures, Operative
7
Sunitinib
7
selpercatinib
6
cabozantinib
6
Nivolumab
6
Fluorodeoxyglucose F18
6
Everolimus
6
pazopanib
5
Vemurafenib
5
Thyroidectomy
5
Specimen Handling
5
Saline Solution
5
Radiotherapy
5
Radiofrequency Ablation
5
Cyclophosphamide
5
Cisplatin
5
Biopsy
5
apatinib
4
anlotinib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Thyroid Neoplasms
×
Sodium Iodide
×
Clear all
NCT01398085
2026-05-07
IoN
University College, London
Phase 2/3
Active not recruiting
504 enrolled